β-blocker in Heart failure with reduced ejection fraction: A review

Journal Title: Nepalese Heart Journal - Year 2013, Vol 10, Issue 1

Abstract

Heart failure, a major public health problem is associated with high mortality, poor quality of life, and frequent hospitalization. It is a complex syndrome characterized by neurohumoral activation. Activation of sympathetic nervous system plays an important role in its pathogenesis. Randomized trials have show that β-blockers reduce mortality, hospitalization and improves quality of life. One of the three β-blockers (i.e., bisoprolol, carvedilol, and sustained-release metoprolol succinate) is recommended for all patients with current or prior symptoms of Heart Failure, unless contraindicated, to reduce morbidity and mortality. β-blockers are underused in patients with heart failure. If a patient is considered suitable for β-blocker therapy, a careful initiation and gradual increases of β-blocker dose are crucial to avoid clinical deterioration. Initiating the Angiotensin Conventing Enzyme inhibitor first is traditional but studies have proven similar safety with a β-blocker-first strategy. Emerging evidence suggests that the order of initial ACEI or β-blocker therapy may not matter.

Authors and Affiliations

Chandra Mani Adhikari| Department of cardiology, Shahid Gangalal National Heart Centre,Kathmandu,Nepal

Keywords

Related Articles

β-blocker in Heart failure with reduced ejection fraction: A review

Heart failure, a major public health problem is associated with high mortality, poor quality of life, and frequent hospitalization. It is a complex syndrome characterized by neurohumoral activation. Activation of sympath...

Observational Study of Pulmonary Embolism Patients in Shahid Gangalal National Heart Centre

Pulmonary thromboembolism (PE) is a relatively common cardiovascular emergency, with a signifcant mortality and morbidity often precipitated by deep venous thrombosis (DVT).It is considered as the third most common cardi...

Study of the Side effects profle of different anthypertensive drugs among the Hypertensive patent

Hypertension is the leading cause of morbidity and mortality worldwide. Because hypertension is usually asymptomatc yet requires long term therapy, consideraton of potental of undesirable effects of drugs used for its...

Sleep Apnea-A Review

Sleep apnea literally means “cessation of breath.” Sleep apnea is a common disorder in which we have one or more pauses in breathing or shallow breaths during our sleep. Breathing pauses can last from a few seconds t...

Predictors of in-hospital mortality following mitral or double valve replacement for rheumatic heart disease

Backgrounds and Aims: Factors affecting outcome of mitral valve replacement in rheumatic population of Nepal is unknown. The aim of this study was to identify the predictors of in-hospital mortality in patients undergo...

Download PDF file
  • EP ID EP15729
  • DOI http://dx.doi.org/10.3126/njh.v10i1.9746
  • Views 400
  • Downloads 18

How To Cite

Chandra Mani Adhikari (2013). β-blocker in Heart failure with reduced ejection fraction: A review. Nepalese Heart Journal, 10(1), 38-45. https://europub.co.uk/articles/-A-15729